Tag: PIK3CA

Cancer Drug Shows Promise in Treating Infants With Rare Disease That Causes Tissue Overgrowth

January 26, 2022
Mindzilla

New York, NY — PIK3CA-related overgrowth spectrum (PROS) is a group of rare, incurable disorders caused by mutations in the PIK3CA gene that result in the malformation and overgrowth of various parts...

New Analytical Model Detects Mutations in Breast Cancer

September 28, 2020
Mindzilla

Lund, Sweden — Researchers at Lund University in Sweden have developed a computational model which is effective in detecting and identifying genetic mutations in breast tumours. The study, the largest...

Researchers Clarify Role of Mutations in Glioblastoma

July 12, 2018
Mindzilla

Chapel Hill, NC — Researchers have discovered how different mutations in a specific gene help drive glioblastoma, the most lethal form of brain cancer.

Blood Test Helps Predict Effectiveness of Drug Palbociclib on Breast Cancer Patients

March 1, 2018
Mindzilla

London, UK – A new study has found a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests.

T&C

Privacy